Literature DB >> 11488729

Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder.

P J Westenend1, J A Stoop, J G Hendriks.   

Abstract

OBJECTIVE: To assess high-risk human papillomavirus (HPV), mainly HPV type 16, 18, 31 and 33 (an important aetiological factor in squamous cell carcinoma, SCC, of the anogenital region) in SCC of the urinary bladder.
MATERIAL AND METHODS: Sixteen SCC from the urinary bladder were evaluated using non-isotopic in situ hybridization with a sensitive detection system for the presence of high-risk HPV 16/18, or 31/33/51, and for HPV6/11, a low-risk type commonly found in condylomata. Previously published studies were also reviewed and assessed.
RESULTS: No high-risk HPV was found in any of the SCC of the bladder evaluated. Previous reports identified nine HPV-positive SCC of a total of 105, including the present series. In four of these positive cases, HPV types were found that are considered a high risk in anogenital carcinomas.
CONCLUSION: From the present and previous results, we conclude that HPV has no major role in the pathogenesis of SCC of the urinary bladder.

Entities:  

Mesh:

Year:  2001        PMID: 11488729     DOI: 10.1046/j.1464-410x.2001.02230.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

Review 2.  [Squamous cell lesions of the urinary bladder].

Authors:  S Rausch; N Gaisa; R F Youssef; Y Lotan; A Stenzl; T Kälble
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

3.  Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients.

Authors:  Hala Badawi; Hanem Ahmed; Ahmed Ismail; Manal Diab; Magd Moubarak; Afkar Badawy; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-10-08

4.  The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder.

Authors:  Riley E Alexander; Sean R Williamson; Justin Richey; Antonio Lopez-Beltran; Rodolfo Montironi; Darrell D Davidson; Muhammad T Idrees; Carol L Jones; Shaobo Zhang; Lisha Wang; Qiu Rao; Jose A Pedrosa; Hristos Z Kaimakliotis; M Francesca Monn; Michael O Koch; Liang Cheng
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 5.  Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review.

Authors:  Narcisa Muresu; Biagio Di Lorenzo; Laura Saderi; Illari Sechi; Arcadia Del Rio; Andrea Piana; Giovanni Sotgiu
Journal:  Diagnostics (Basel)       Date:  2022-07-20

6.  HRAS mutations are frequent in inverted urothelial neoplasms.

Authors:  Andrew S McDaniel; Yali Zhai; Kathleen R Cho; Saravana M Dhanasekaran; Jeffrey S Montgomery; Ganesh Palapattu; Javed Siddiqui; Todd Morgan; Ajjai Alva; Alon Weizer; Cheryl T Lee; Arul M Chinnaiyan; Michael J Quist; Catherine S Grasso; Scott A Tomlins; Rohit Mehra
Journal:  Hum Pathol       Date:  2014-06-18       Impact factor: 3.466

Review 7.  Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches.

Authors:  Jeremy W Martin; Estrella M Carballido; Ahmed Ahmed; Bilal Farhan; Rahul Dutta; Cody Smith; Ramy F Youssef
Journal:  Arab J Urol       Date:  2016-08-01

8.  Bladder cancer and human papillomavirus association: a systematic review and meta-analysis.

Authors:  Alireza Khatami; Zahra Salavatiha; Mohammad Hossein Razizadeh
Journal:  Infect Agent Cancer       Date:  2022-01-21       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.